Skip to main content

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

[widgetkit id="1" name="CC Event Nav"]

Escherichia Coli Community-Acquired Pneumonia

Phase 3 Trials Show Omadacycline’s Efficacy Against Molecularly Characterized Gram-Positive and Gram-Negative Pathogens Causing Infections

Geographic Distribution of Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae Across Veterans Health Administration Outpatient Settings

Omadacycline In Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms

Acalabrutinib with Obinutuzumab in Relapsed/Refractory and Treatment-Naïve Patients with CLL: The Phase 1b/2 ACE-CL-003 Study

Adverse Events, Resource Use, and Economic Burden in Patients with Mantle-Cell Lymphoma in the United States

High Complete Response Rates with Pembrolizumab with Rituximab in Patients with Relapsed FL: Results of an Open-Label, Phase 2 Study

Efficacy and Safety of Bendamustine and Rituximab as First Salvage Treatment in CLL: Results of the GIMEMA-ERIC LLC1315 Study

Phase 1/2 Study of Pembrolizumab in Combination with Ublituximab (TG-1101) and Umbralisib (TGR-1202) in Patients with Relapsed/Refractory CLL

Randomized Trial of Ibrutinib versus Ibrutinib plus Rituximab in Patients with CLL

Page 10 of 25
Results 91 - 100 of 242